Single-cell network profiling (SCNP) by flow cytometry in autoimmune disease

References

• Fox DA. Biological therapies: A novel approach to the treatment of autoimmune disease. Am J Med. 1995; 99 1: 82–88.
   PubMed Web of Science ®Google Scholar
• Genovese MC. Biologic therapies in clinical development for the treatment of rheumatoid arthritis. J Clin Rheumatol. 2005; 11 3 Suppl: S45–S54.
   PubMed Web of Science ®Google Scholar
• Puppo F, Murdaca G, Ghio M, Indiveri F. Emerging biologic drugs for the treatment of rheumatoid arthritis. Autoimmun Rev. 2005; 4 8: 537–541.
   PubMed Web of Science ®Google Scholar
• Cook AD, Visvanathan K. Molecular targets in immune-mediated diseases: Focus on rheumatoid arthritis. Expert Opin Ther Targets. 2004; 8 5: 375–390.
   PubMed Web of Science ®Google Scholar
• Weiner HL. The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease?. Ann Neurol. 2009; 65 3: 239–248.
   PubMed Web of Science ®Google Scholar
• Meriggioli MN. Myasthenia gravis with anti-acetylcholine receptor antibodies. Front Neurol Neurosci. 2009; 26:94–108.
   PubMedGoogle Scholar
• McFarland HF, Martin R. Multiple sclerosis: A complicated picture of autoimmunity. Nat Immunol. 2007; 8 9: 913–919.
   PubMed Web of Science ®Google Scholar
• Parkinson DR, Cesano A. Patient-specific classifications of human malignant disease. Curr Opin Mol Ther. 2009; 11 3: 252–259.
   PubMedGoogle Scholar
• Perez OD, Krutzik PO, Nolan GP. Flow cytometric analysis of kinase signaling cascades. Methods Mol Biol. 2004; 263:67–94.
   PubMedGoogle Scholar
• Perez OD, Mitchell D, Campos R, Gao GJ, Li L, Nolan GP. Multiparameter analysis of intracellular phosphoepitopes in immunophenotyped cell populations by flow cytometry. Curr Protoc Cytom. 2005 Chapter 6: p. Unit 6 20.
   PubMedGoogle Scholar
• Krutzik PO, Hale MB, Nolan GP. Characterization of the murine immunological signaling network with phosphospecific flow cytometry. J Immunol. 2005; 175 4: 2366–2373.
   PubMed Web of Science ®Google Scholar
• Perez OD, Nolan GP. Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat Biotechnol. 2002; 20 2: 155–162.
   PubMed Web of Science ®Google Scholar
• Krutzik PO, Irish JM, Nolan GP, Perez OD. Analysis of protein phosphorylation and cellular signaling events by flow cytometry: Techniques and clinical applications. Clin Immunol. 2004; 110 3: 206–221.
   PubMed Web of Science ®Google Scholar
• Nolan GP. What's wrong with drug screening today. Nat Chem Biol. 2007; 3 4: 187–191.
   PubMed Web of Science ®Google Scholar
• De Rosa SC, Roederer M. Eleven-color flow cytometry. A powerful tool for elucidation of the complex immune system. Clin Lab Med. 2001; 21 4: 697–712 vii.
   PubMed Web of Science ®Google Scholar
• Leslie D, Lipsky P, Notkins AL. Autoantibodies as predictors of disease. J Clin Invest. 2001; 108 10: 1417–1422.
   PubMed Web of Science ®Google Scholar
• Irish JM, Czerwinski DK, Nolan GP, Levy R. Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry. J Immunol. 2006; 177 3: 1581–1589.
   PubMed Web of Science ®Google Scholar
• Jenks SA, Sanz I. Altered B cell receptor signaling in human systemic lupus erythematosus. Autoimmun Rev. 2009; 8 3: 209–213.
   PubMed Web of Science ®Google Scholar
• Liossis SN, Vassilopoulos D, Kovacs B, Tsokos GC. Immune cell biochemical abnormalities in systemic lupus erythematosus. Clin Exp Rheumatol. 1997; 15 6: 677–684.
   PubMed Web of Science ®Google Scholar
• Tsokos GC, Liossi SN. Immune cell signaling defects in lupus: Activation, anergy and death. Immunol Today. 1999; 20 3: 119–124.
   PubMedGoogle Scholar
• D'Aura Swanson C, Paniagua RT, Lindstrom TM, Robinson WH. Tyrosine kinases as targets for the treatment of rheumatoid arthritis. Nat Rev Rheumatol. 2009; 5 6: 317–324.
   PubMed Web of Science ®Google Scholar
• Hale MB, Krutzik PO, Samra SS, Crane JM, Nolan GP. Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus. PLoS ONE. 2009; 4 8: e6756.
   Web of Science ®Google Scholar
• Liossis SN, Kovacs B, Dennis G, Kammer GM, Tsokos GC. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. J Clin Invest. 1996; 98 11: 2549–2557.
   PubMed Web of Science ®Google Scholar
• Baechler EC, Gregersen PK, Behrens TW. The emerging role of interferon in human systemic lupus erythematosus. Curr Opin Immunol. 2004; 16 6: 801–807.
   PubMed Web of Science ®Google Scholar
• Grammer AC, Fischer R, Lee O, Zhang X, Lipsky PE. Flow cytometric assessment of the signaling status of human B lymphocytes from normal and autoimmune individuals. Arthritis Res Ther. 2004; 6 1: 28–38.
   PubMed Web of Science ®Google Scholar
• Wong CK, Wong PT, Tam LS, Li EK, Chen DP, Lam CW. Activation profile of intracellular mitogen-activated protein kinases in peripheral lymphocytes of patients with systemic lupus erythematosus. J Clin Immunol. 2009.
   Web of Science ®Google Scholar
• Galligan CL, Siebert JC, Siminovitch KA, Keystone EC, Bykerk V, Perez OD, Fish EN. Multiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: Implications for diagnosis and monitoring drug therapy. PLoS ONE. 2009; 4 8: e6703.
   Web of Science ®Google Scholar
• Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud O, Gjertsen BT, Nolan GP. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell. 2004; 118 2: 217–228.
   PubMed Web of Science ®Google Scholar
• Kotecha N, Flores NJ, Irish JM, Simonds EF, Sakai DS, Archambeault S, Diaz-Flores E, Coram M, Shannon KM, Nolan GP, Loh ML. Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell. 2008; 14 4: 335–343.
   PubMed Web of Science ®Google Scholar
• Donahue AC, Fruman DA. Distinct signaling mechanisms activate the target of rapamycin in response to different B-cell stimuli. Eur J Immunol. 2007; 37 10: 2923–2936.
   PubMed Web of Science ®Google Scholar
• Donahue AC, Kharas MG, Fruman DA. Measuring phosphorylated Akt and other phosphoinositide 3-kinase-regulated phosphoproteins in primary lymphocytes. Methods Enzymol. 2007; 434:131–154.
   PubMed Web of Science ®Google Scholar
• Bardet V, Tamburini J, Ifrah N, Dreyfus F, Mayeux P, Bouscary D, Lacombe C. Single cell analysis of phosphoinositide 3-kinase/Akt and ERK activation in acute myeloid leukemia by flow cytometry. Haematologica. 2006; 91 6: 757–764.
   PubMed Web of Science ®Google Scholar
• Krutzik PO, Crane JM, Clutter MR, Nolan GP. High-content single-cell drug screening with phosphospecific flow cytometry. Nat Chem Biol. 2008; 4 2: 132–142.
   PubMed Web of Science ®Google Scholar
• Dahl ME, Berson A, Lora J, Fuentes M. A novel CCR5-specific pharmacodynamic assay in whole blood using phosphoflow cytometry highlights different ligand-dependent responses but similar properties of antagonists in CD8+ and CD4+ T lymphocytes. J Pharmacol Exp Ther. 2008; 327 3: 926–933.
   PubMed Web of Science ®Google Scholar
• Chow S, Patel H, Hedley DW. Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: Potential for pharmacodynamic monitoring of signal transduction inhibitors. Cytometry. 2001; 46 2: 72–78.
   PubMedGoogle Scholar
• Edwards BS, Oprea T, Prossnitz ER, Sklar LA. Flow cytometry for high-throughput, high-content screening. Curr Opin Chem Biol. 2004; 8 4: 392–398.
   PubMed Web of Science ®Google Scholar
• Krutzik PO, Nolan GP. Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Methods. 2006; 3 5: 361–368.
   PubMed Web of Science ®Google Scholar
• Motlekar N, Diamond SL, Napper AD. Evaluation of an orthogonal pooling strategy for rapid high-throughput screening of proteases. Assay Drug Dev Technol. 2008; 6 3: 395–405.
   PubMed Web of Science ®Google Scholar
• Elliott G, Lin C-H, Escobar S, Stanton R, Rowe T, Gulrajani M, Walling L, Dunne J. Post-treatment pooling: A simple method to enhance sample throughput for screening small molecule libraries. International Society for Analytical Cytology XXIV. 2008. Budapest, Hungary. p. 182.
   Google Scholar
• Covey TM, Putta S, Cesano A. Single Cell Network Profiling (SCNP) applications in drug development: Mapping the complex signaling network of drug and target interactions at the single cell level. Assay Drug Dev Technol 2010 Feb 17 [Epub ahead of print].
   Google Scholar
• Hotson AN, Hardy JW, Hale MB, Contag CH, Nolan GP. The T cell STAT signaling network is reprogrammed within hours of bacteremia via secondary signals. J Immunol. 2009; 182 12: 7558–7568.
   PubMed Web of Science ®Google Scholar
• Green LJ, Marder P, Ray C, Cook CA, Jaken S, Musib LC, Herbst RS, Carducci M, Britten CD, Basche M, Eckhardt SG, Thornton D. Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-beta inhibitor. Clin Cancer Res. 2006; 12 11 Pt 1: 3408–3415.
   PubMed Web of Science ®Google Scholar
• Tong FK, Chow S, Hedley D. Pharmacodynamic monitoring of BAY 43-9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells. Cytom B Clin Cytom. 2006; 70 3: 107–114.
   PubMedGoogle Scholar
• Hedley DW, Chow S, Goolsby C, Shankey TV. Pharmacodynamic monitoring of molecular-targeted agents in the peripheral blood of leukemia patients using flow cytometry. Toxicol Pathol. 2008; 36 1: 133–139.
   PubMed Web of Science ®Google Scholar
• Chung EJ, Lee S, Sausville EA, Ryan Q, Karp JE, Gojo I, Telford WG, Lee MJ, Kong HS, Trepel JB. Histone deacetylase inhibitor pharmacodynamic analysis by multiparameter flow cytometry. Ann Clin Lab Sci. 2005; 35 4: 397–406.
   PubMed Web of Science ®Google Scholar
• Hubert P, Grenot P, Autran B, Debre P. Analysis by flow cytometry of tyrosine-phosphorylated proteins in activated T-cell subsets on whole blood samples. Cytometry. 1997; 29 1: 83–91.
   PubMedGoogle Scholar
• Covey T, Mu S, Saris CJM. Monitoring signal transduction in whole blood by flow cytometry. Exp Biol FASEB. 2005 San Diego, CA. abstract #12201.
   Google Scholar
• Chow S, Hedley D, Shankey TV. Whole blood processing for measurement of signaling proteins by flow cytometry. Curr Protoc Cytom. 20081–9 Chapter 9: p. Unit 9 27.
   Google Scholar
• Kornblau S, Minden MD, Rosen DB, Putta S, Cohen AC, Covey T, Fantl WJ, Gayko U, Cesano A. Single cell network profiles in non-M3 AML associated with patient response to standard induction therapy. Blood (ASH Annual Meeting Abstracts). 2009; 114:1582.
   Web of Science ®Google Scholar